Access the full text.
Sign up today, get DeepDyve free for 14 days.
Chunyan Wang, Wentao Li, D. Drabek, Nisreen Okba, R. Haperen, A. Osterhaus, F. Kuppeveld, B. Haagmans, F. Grosveld, B. Bosch (2020)
A human monoclonal antibody blocking SARS-CoV-2 infectionNature Communications, 11
Xiaonan Zhang, Yun Tan, Y. Ling, G. Lu, Feng Liu, Zhigang Yi, Xiaofang Jia, Min Wu, Bisheng Shi, Shuibao Xu, Jun Chen, W. Wang, Bing Chen, Lu Jiang, Shuting Yu, Jing Lu, Jinzeng Wang, Mingzhu Xu, Zhenghong Yuan, Qin Zhang, Xinxin Zhang, Guoping Zhao, Shengyue Wang, Saijuan Chen, Hongzhou Lu (2020)
Viral and host factors related to the clinical outcome of COVID-19Nature
M. Hoffmann, Hannah Kleine-Weber, S. Schroeder, Nadine Krüger, T. Herrler, Sandra Erichsen, T. Schiergens, G. Herrler, N. Wu, A. Nitsche, M. Müller, C. Drosten, S. Pöhlmann (2020)
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease InhibitorCell, 181
Yuxian He, Yusen Zhou, Shuwen Liu, Z. Kou, Wenhui Li, M. Farzan, Shibo Jiang (2004)
Receptor-binding domain of SARS-CoV spike protein induces highly potent neutralizing antibodies: implication for developing subunit vaccineBiochemical and Biophysical Research Communications, 324
P. Zhou, Xing-Lou Yang, Xian-Guang Wang, Ben Hu, Lei Zhang, Wei Zhang, Hao-rui Si, Yan Zhu, Bei Li, Chao Huang, Hui-Dong Chen, Jing Chen, Yun Luo, Hua Guo, Ren-di Jiang, Mei Liu, Ying Chen, Xurui Shen, Xi Wang, Xiao-Shuang Zheng, Kai Zhao, Quanjiao Chen, F. Dèng, Lin-lin Liu, Bing-Ru Yan, F. Zhan, Yan-Yi Wang, Geng-Fu Xiao, Z. Shí (2020)
A pneumonia outbreak associated with a new coronavirus of probable bat originNature, 579
Wong (2003)
199Hong Kong Med J, 9
J. Griensven, T. Edwards, X. Lamballerie, Malcolm Semple, P. Gallian, S. Baize, P. Horby, H. Raoul, N. Magassouba, A. Antierens, Carolyn Lomas, O. Faye, A. Sall, K. Fransen, J. Buyze, R. Ravinetto, P. Tiberghien, Y. Claeys, Maaike Crop, L. Lynen, E. Bah, Peter Smith, A. Delamou, A. Weggheleire, N. Haba (2016)
Evaluation of Convalescent Plasma for Ebola Virus Disease in Guinea.The New England journal of medicine, 374 1
A. Casadevall, L. Pirofski (2020)
The convalescent sera option for containing COVID-19.The Journal of clinical investigation
Clinical Characteristics and Neutralizing Antibody Levels in Patients Who Have Recovered From Mild COVID-19 Original Investigation Research jamainternalmedicine.com (Reprinted) JAMA Internal Medicine
K. Hong, Jae-phil Choi, Seon-Hui Hong, Jeewon Lee, Ji-Soo Kwon, Sun-mi Kim, S. Park, J. Rhee, Baek-Nam Kim, H. Choi, E. Shin, H. Pai, Su‐Hyung Park, Sung-Han Kim (2017)
Predictors of mortality in Middle East respiratory syndrome (MERS)Thorax, 73
(2020)
Characteristics of and important lessons from the coronavirus disease and Prevention
Zunyou Wu, J. McGoogan (2020)
Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention.JAMA
Fan Wu, Su Zhao, Bin Yu, Yan-Mei Chen, Wen Wang, Zhigang Song, Y. Hu, Zhaowu Tao, Jun-hua Tian, Yuan-Yuan Pei, Mingli Yuan, Yuling Zhang, Fahui Dai, Yi Liu, Qimin Wang, Jiao-Jiao Zheng, Lin Xu, E. Holmes, Yong‐Zhen Zhang (2020)
A new coronavirus associated with human respiratory disease in ChinaNature, 579
Yingxia Liu, Yang Yang, Cong Zhang, Fengming Huang, Fuxiang Wang, Jing Yuan, Zhaoqin Wang, Jin-xiu Li, Jianming Li, C. Feng, Zheng Zhang, Lifei Wang, Ling Peng, Li Chen, Yuhao Qin, Dandan Zhao, Shuguang Tan, Lu Yin, Jun Xu, Congzhao Zhou, Chengyu Jiang, Lei Liu (2020)
Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injuryScience China. Life Sciences, 63
Boping Zhou, Nanshan Zhong, Y. Guan (2007)
Treatment with convalescent plasma for influenza A (H5N1) infection.The New England journal of medicine, 357 14
M. Katz (2020)
Neutralizing Antibodies Against SARS-CoV-2-Important Questions, Unclear Answers.JAMA internal medicine
R. Zinkernagel (2003)
On natural and artificial vaccinations.Annual review of immunology, 21
F. Zhou, Ting Yu, R. Du, Guohui Fan, Y. Liu, Zhibo Liu, J. Xiang, Ye-ming Wang, Bin Song, Xiaoying Gu, Lulu Guan, Yuan Wei, Hui Li, Xudong Wu, Jiuyang Xu, Shengjin Tu, Yi Zhang, Hua Chen, B. Cao (2020)
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort studyLancet (London, England), 395
World Health Organization. Coronavirus disease 2019 (COVID-19) situation report
Shuai Xia, Meiqin Liu, Chao Wang, W. Xu, Qiaoshuai Lan, Siliang Feng, F. Qi, L. Bao, L. Du, Shuwen Liu, C. Qin, Fei Sun, Z. Shí, Yun Zhu, Shibo Jiang, Lu Lu (2020)
Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusionCell Research, 30
J. Peiris, C. Chu, V. Cheng, Ks Chan, I. Hung, L. Poon, K. Law, B. Tang, T. Hon, C. Chan, K. Chan, Jsc Ng, B. Zheng, W. Ng, Rwm Lai, Y. Guan, K. Yuen (2003)
Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective studyLancet (London, England), 361
Chenguang Shen, Zhaoqin Wang, Fang Zhao, Yang Yang, Jin-xiu Li, Jing Yuan, Fuxiang Wang, Delin Li, Minghui Yang, L. Xing, Jinli Wei, Haixia Xiao, Yan Yang, J. Qu, L. Qing, Li Chen, Zhixiang Xu, Ling Peng, Yanjie Li, Haixia Zheng, Feng Chen, Kun-Hua Huang, Yujin Jiang, Dongjing Liu, Zheng Zhang, Yingxia Liu, Lei Liu (2020)
Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma.JAMA
S. Smits, A. Lang, J. Brand, L. Leijten, W. Ijcken, M. Eijkemans, G. Amerongen, T. Kuiken, A. Andeweg, A. Osterhaus, B. Haagmans (2010)
Exacerbated Innate Host Response to SARS-CoV in Aged Non-Human PrimatesPLoS Pathogens, 6
T. Burnouf, M. Radosevich (2003)
Treatment of severe acute respiratory syndrome with convalescent plasma.Hong Kong medical journal = Xianggang yi xue za zhi, 9 4
Key PointsQuestionAre clinical characteristics of patients who recovered from mild coronavirus disease 2019 (COVID-19) associated with levels of neutralizing antibodies? FindingsIn this cohort study of 175 patients who recovered from mild COVID-19, neutralizing antibody titers to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) varied substantially at the time of discharge. In addition, neutralizing antibodies were not detected in 10 patients. MeaningFurther research is needed to understand the implications of variable levels of SARS-CoV-2–specific neutralizing antibodies for protection against future infections with SARS-CoV-2.
JAMA Internal Medicine – American Medical Association
Published: Oct 18, 2020
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.